Allarity Therapeutics (NASDAQ:ALLR) Shares to Reverse Split on Tuesday, April 9th

Shares of Allarity Therapeutics, Inc. (NASDAQ:ALLR) are going to reverse split on Tuesday, April 9th. The 1-20 reverse split was announced on Tuesday, April 9th. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, April 9th.

Allarity Therapeutics Price Performance

NASDAQ:ALLR opened at $0.23 on Friday. Allarity Therapeutics has a 12 month low of $0.21 and a 12 month high of $154.40. The business’s fifty day moving average price is $0.38 and its 200 day moving average price is $0.50.

Hedge Funds Weigh In On Allarity Therapeutics

Hedge funds have recently modified their holdings of the business. Renaissance Technologies LLC acquired a new stake in shares of Allarity Therapeutics during the first quarter worth $233,000. Armistice Capital LLC purchased a new position in shares of Allarity Therapeutics during the 3rd quarter worth approximately $195,000. Finally, Sabby Management LLC acquired a new stake in shares of Allarity Therapeutics in the 3rd quarter valued at approximately $268,000. 11.53% of the stock is currently owned by hedge funds and other institutional investors.

Allarity Therapeutics Company Profile

Allarity Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor in phase 2 for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme.